vic3308

º²É­ÖÆÒ© º²É­ÖÆÒ©

ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾ ¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • vic3308¥Y
ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾
ÐÂÎÅÐû²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅÐû²¼
º²É­ÖÆÒ©Ê¥ÂÞÀ³?ÖÎÁÆ·Ç͸ÎöCKDѪÐ黼ÕߢóÆÚÁÙ´²Ñо¿ÔÚ¹ú¼ÊÆÚ¿¯Kidney International ReportsÐû²¼
Ðû²¼ÈÕÆÚ£º2024/12/25
×ÖºÅ

¿ËÈÕ £¬£¬£¬£¬£¬£¬¹ú¼ÊÉöÔಡÁìÓòÖøÃûÆÚ¿¯Kidney International Reports£¨IF£º5.7/Q1)ÔÚÏß½ÒÏþÁËÓɹ㶫ʡÈËÃñÒ½ÔºÓàѧÇå½ÌÊÚǣͷµÄÅàĪɳëÄ×¢ÉäÒº£¨ÉÌÆ·Ãû£ºÊ¥ÂÞÀ³?£©ÔÚ·Ç͸ÎöÉöÐÔѪÐ黼ÕßÖпªÕ¹µÄ¢óÆÚÁÙ´²Ñо¿Êý¾Ý¡£¡£¡£¡£¡£¡£¡£

Ê¥ÂÞÀ³?ÊÇÏÖÔÚÈ«ÇòΨһ»ñÅúÉÏÊеÄEPOÄ£ÄâëÄ £¬£¬£¬£¬£¬£¬ÆäÕë¶Ô͸ÎöÉöÐÔѪÐ黼ÕߵĢóÆÚ×¢²áÁÙ´²Ñо¿Ð§¹ûÒÑÓÚ2023Äê10ÔÂÔÚÁøÒ¶µ¶×Ó¿¯eClinicalMedicineÉϽÒÏþ1¡£¡£¡£¡£¡£¡£¡£¸ÃÑо¿ÅúעÿÔÂ1´ÎƤÏÂ×¢ÉäÅàĪɳëÄÖÎÁÆÖйú͸Îö»¼ÕßѪÐé £¬£¬£¬£¬£¬£¬ÔÚÁÆЧÉÏ·ÇÁÓÓÚͨÀýÿÖÜ1~3´Î°¢·¨ÒÀ²´Í¡ÖÎÁÆ £¬£¬£¬£¬£¬£¬ÉõÖÁ¾ßÓиüÓŵÄÇ÷ÊÆ £¬£¬£¬£¬£¬£¬ÇÒÇå¾²ÐÔÏ൱1¡£¡£¡£¡£¡£¡£¡£

´Ë´ÎKidney International Reports½ÒÏþµÄÊ¥ÂÞÀ³? ÖÎÁÆ·Ç͸ÎöCKDѪÐ黼ÕߢóÆÚÁÙ´²Ñо¿ÏÔʾ £¬£¬£¬£¬£¬£¬ÔÚÖйú·Ç͸ÎöÉöÐÔѪÐ黼ÕßÖÐ £¬£¬£¬£¬£¬£¬ÅàĪɳëĽöÐè4ÖÜ1´ÎƤÏÂ×¢Éä £¬£¬£¬£¬£¬£¬¾ÍÄִܵïÓëͨÀý°¢·¨ÒÀ²´Í¡Í¬ÑùÁÆЧ £¬£¬£¬£¬£¬£¬ÇÒÐÄѪ¹Ü²»Á¼ÊÂÎñ±¬·¢ÂʸüµÍ2 £¬£¬£¬£¬£¬£¬Õ⽫ΪÅàĪɳëÄÔÚ·Ç͸ÎöCKDѪÐ黼ÕßÖеÄÓ¦ÓÃÌṩÓÐÁ¦Ö§³Ö £¬£¬£¬£¬£¬£¬ÏêϸÐÅÏ¢ÈçÏ¡£¡£¡£¡£¡£¡£¡£

Ñо¿ÏÈÈÝ




ÅàĪɳëÄÖÎÁÆ·Ç͸ÎöCKD»¼ÕßѪÐéµÄËæ»úÊÔÑé

×÷Õߣº¹ã¶«Ê¡ÈËÃñÒ½ÔºÓàѧÇå½ÌÊÚ  µÈ

ÏòÉÏ»¬¶¯ÔÄÀÀ

¡¾Ñо¿ÒªÁì¡¿

ÕâÏîΪÆÚ52ÖܵĶàÖÐÐÄ¡¢Ëæ»ú¡¢¿ª·Å±êÇ©¡¢ÑôÐÔ±ÈÕÕ¡¢·ÇÁÓЧÐÔIIIÆÚÁÙ´²Ñо¿ £¬£¬£¬£¬£¬£¬¹²ÄÉÈëÀ´×Ôº£ÄÚ38ÆäÖÐÐĵÄ173Àýδ½ÓÊܹýºìϸ°ûÌìÉú´Ì¼¤¼Á£¨ESA£©ÖÎÁƵķÇ͸ÎöÂýÐÔÉöÔಡ£¨CKD-NDD£©Ïà¹ØѪÐ黼Õß £¬£¬£¬£¬£¬£¬Ö¼ÔÚÆÀ¹ÀÅàĪɳëÄ£¨³õʼ¼ÁÁ¿0.04mg/kg £¬£¬£¬£¬£¬£¬Æ¤ÏÂ×¢Éä £¬£¬£¬£¬£¬£¬4ÖÜ1´Î£©±ÈÕÕ°¢·¨ÒÀ²´Í¡£¡£¡£¡£¡£¡£¡£¨³õʼ¼ÁÁ¿6000IU/ÖÜ £¬£¬£¬£¬£¬£¬Æ¤ÏÂ×¢Éä £¬£¬£¬£¬£¬£¬Ã¿1~2ÖÜ1´Î£©ÖÎÁÆ52ÖܵÄÁÆЧºÍÇå¾²ÐÔ¡£¡£¡£¡£¡£¡£¡£Ö÷ÒªÁÆЧÖÕµãΪÁÆЧÆÀ¹ÀÆÚ£¨µÚ17~24ÖÜ£©ÑªºìÂÑ°×£¨HGB£©Æ½¾ùÖµÏà¶Ô»ùÏßµÄת±äÖµ£¨?HGB£©¡£¡£¡£¡£¡£¡£¡£

¡¾Ñо¿Ð§¹û¡¿

Ч¹ûÏÔʾ £¬£¬£¬£¬£¬£¬ÔÚÈ«ÆÊÎö¼¯£¨FAS£©ÖÐ £¬£¬£¬£¬£¬£¬ÅàĪɳëÄ×éÁÆЧÆÀ¹ÀÆÚHb×Ô»ùÏßƽ¾ùÉý¸ß19.2 g/L £¬£¬£¬£¬£¬£¬°¢·¨ÒÀ²´Í¡×éÔòƽ¾ùÉý¸ß15.4g/L £¬£¬£¬£¬£¬£¬Á½×é²î±ðΪ3.8 g/L£¨95% CI £¬£¬£¬£¬£¬£¬0.7-6.9 £¬£¬£¬£¬£¬£¬P= 0.02£© £¬£¬£¬£¬£¬£¬µÖ´ïÔ¤ÉèµÄ·ÇÁÓ±ê×¼¡£¡£¡£¡£¡£¡£¡£ÔÚѪÐé»ñµÃ¾ÀÕýºó £¬£¬£¬£¬£¬£¬Ïà±È±ÈÕÕ×é £¬£¬£¬£¬£¬£¬ÅàĪɳëÄ×éÓиü¶àµÄ»¼ÕßHbˮƽһֱά³ÖÔÚ100~120g/LµÄÄ¿µÄ¹æÄ££¨15.9%vs5.9%£© £¬£¬£¬£¬£¬£¬ÕâÌáÐÑÅàĪɳëĸüÓÐÖúÓÚʵÏÖºã¾ÃÒ»Á¬´ï±ê¡£¡£¡£¡£¡£¡£¡£±ðµÄ £¬£¬£¬£¬£¬£¬Ïà±È±ÈÕÕ×é £¬£¬£¬£¬£¬£¬ÅàĪɳëÄ×éÐèÒª½ÏÉٵļÁÁ¿µ÷½â´ÎÊý¾ÍÄÜʵÏÖHb´ï±ê¡£¡£¡£¡£¡£¡£¡£

Çå¾²ÐÔ·½Ãæ £¬£¬£¬£¬£¬£¬Á½×é×ÜÌåÉϲ»Á¼ÊÂÎñ±¬·¢ÂÊÏ൱ £¬£¬£¬£¬£¬£¬µ«ÅàĪɳëÄ×éÖÎÁÆÏà¹Ø²»Á¼ÊÂÎñ£¨AE£©±¬·¢ÂʸüµÍ£¨19.1% vs 29.3%£©¡£¡£¡£¡£¡£¡£¡£ÖµµÃ×¢ÖصÄÊÇ £¬£¬£¬£¬£¬£¬ÅàĪɳëÄ×éµÄ¸´ºÏÇå¾²ÐÔÊÂÎñ£¨0.9% vs 3.4%£©ºÍÆäËûÐÄѪ¹ÜÊÂÎñ±¬·¢ÂÊ£¨0% vs 5.2%£©¾ùµÍÓÚ°¢·¨ÒÀ²´Í¡×é¡£¡£¡£¡£¡£¡£¡£±ðµÄ £¬£¬£¬£¬£¬£¬ÅàĪɳëÄ×éδ·ºÆðÓëÑо¿Ò©ÎïÏà¹ØµÄ¹ýÃô·´Ó¦ £¬£¬£¬£¬£¬£¬Ò²Î´·ºÆðÆäËû·ÇÔ¤ÆÚÑÏÖز»Á¼·´Ó¦ÊÂÎñ¡£¡£¡£¡£¡£¡£¡£

¡¾Ñо¿½áÂÛ¡¿

¸ÃÑо¿Åú×¢ £¬£¬£¬£¬£¬£¬ÔÚÖйú·Ç͸ÎöÉöÐÔѪÐ黼ÕßÖÐ £¬£¬£¬£¬£¬£¬ÅàĪɳëĽöÐè4ÖÜ1´ÎƤÏÂ×¢Éä £¬£¬£¬£¬£¬£¬¾ÍÄִܵïÓëͨÀý°¢·¨ÒÀ²´Í¡Í¬ÑùÁÆЧ £¬£¬£¬£¬£¬£¬ÇÒÐÄѪ¹Ü²»Á¼ÊÂÎñ±¬·¢ÂʸüµÍ¡£¡£¡£¡£¡£¡£¡£Õ⽫ΪÅàĪɳëÄÔÚ·Ç͸ÎöCKDѪÐ黼ÕßÖеÄÓ¦ÓÃÌṩÓÐÁ¦Ö§³Ö¡£¡£¡£¡£¡£¡£¡£

¹ØÓÚÊ¥ÂÞÀ³?

Ê¥ÂÞÀ³?ÊǺ²É­ÖÆÒ©×ÔÖ÷Ñз¢µÄÈ«ÇòΨһ»ñÅúÉÏÊеÄEPOÄ£ÄâëÄ £¬£¬£¬£¬£¬£¬ÎªÐÂÐͳ¤Ð§ESAÀàÒ©Îï¡£¡£¡£¡£¡£¡£¡£Ê¥ÂÞÀ³?ÓÚ2023Äê6Ô»ñÖйú¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨NMPA£©Åú×¼ÉÏÊÐ £¬£¬£¬£¬£¬£¬ÊÊÓÃÓÚÖÎÁÆÒòCKDÒýÆðµÄѪÐé £¬£¬£¬£¬£¬£¬°üÀ¨Î´½ÓÊÜESAÖÎÁƵijÉÈË·Ç͸Îö»¼Õß £¬£¬£¬£¬£¬£¬¼°ÕýÔÚ½ÓÊܶÌЧEPOÖÎÁƵijÉÈË͸Îö»¼Õß¡£¡£¡£¡£¡£¡£¡£Ê¥ÂÞÀ³?ÊǺ²É­ÖÆÒ©»ñÅúÉÏÊеĵÚ7¿îÁ¢ÒìÒ© £¬£¬£¬£¬£¬£¬Ò²ÊǺ²É­ÖÆÒ©Ê׿îͬʱ»ñÅúÁ½Ïî˳Ӧ֢µÄÁ¢ÒìÒ©¡£¡£¡£¡£¡£¡£¡£


¹ØÓÚKidney International Reports

Kidney International Reports£¨ÆÚ¿¯ISSN£º2468-0249 £¬£¬£¬£¬£¬£¬ eISSN£º2468-0249£©Êǹú¼ÊÉöÔಡѧ»áµÄ¹Ù·½ÆÚ¿¯ £¬£¬£¬£¬£¬£¬ÊÇÒ»±¾ÙÉÐÐÆÀÉóµÄ¿ª·Å»ñÈ¡ÆÚ¿¯ £¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ½ÒÏþÓëÉöÔ༲²¡Ïà¹ØµÄÁìÏÈÑо¿ºÍÉú³¤¡£¡£¡£¡£¡£¡£¡£¸ÃÔÓÖ¾µÄÖ÷ҪĿµÄÊÇΪ¸ÄÉÆÉöÔ༲²¡»¼ÕßµÄÕչ˻¤Ê¿×ö³öТ˳ £¬£¬£¬£¬£¬£¬½ÒÏþÓë¼±ÐÔºÍÂýÐÔÉöÔ༲²¡¡¢ÖÕÄ©ÆÚÉöÔ༲²¡¡¢ÒÆÖ²¡¢Ëá¼î¡¢ÒºÌåºÍµç½âÖÊÔÓÂÒÒÔ¼°¸ßѪѹµÄ·¢²¡»úÖÆ¡¢ÆÀ¹ÀºÍÖÎÀíÏà¹ØµÄÔ­´´ÁÙ´²ºÍ¾«Ñ¡·­ÒëÎÄÕºͽÌÓýÄÚÈÝ¡£¡£¡£¡£¡£¡£¡£Kidney International Reports 2023Äê×îÐÂÆÚ¿¯Ó°ÏìÒò×ÓΪ5.7 £¬£¬£¬£¬£¬£¬ÔÚÈ«Çò126ÖÖ ¡°ÃÚÄòѧÓëÉöÔàѧ¡±ÆÚ¿¯ÖÐÅÅÃûµÚ11λ £¬£¬£¬£¬£¬£¬Q1Çø¡£¡£¡£¡£¡£¡£¡£


¹ØÓÚº²É­ÖÆÒ©

º²É­ÖÆÒ©ÊÇÖйúÁìÏȵÄÁ¢ÒìÇý¶¯ÐÍÖÆÒ©ÆóÒµ £¬£¬£¬£¬£¬£¬ÏÂÊôºÀÉ­Ò©Òµ¡¢³£Öݺã°îÒ©Òµ¡¢º²É­ÉúÎïÒ½Ò©µÈ×Ó¹«Ë¾ £¬£¬£¬£¬£¬£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹Ñ¬È¾¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò £¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚͨ¹ýÒ»Á¬Á¢ÒìÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£¡£¡£¡£¡£¡£¡£×èÖ¹2024ÉÏ°ëÄê £¬£¬£¬£¬£¬£¬¹«Ë¾ÒÑÉÏÊÐ7¿îÁ¢ÒìÒ© £¬£¬£¬£¬£¬£¬Á¢Òì²úÆ·ÓªÊÕÕ¼±È´ï77.4%¡£¡£¡£¡£¡£¡£¡£¹«Ë¾Ò»Á¬¶àÄêλ¾ÓÈ«ÇòÖÆÒ©ÆóÒµ°ÙÇ¿¡¢ÖйúÒ½Ò©Ñз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿ £¬£¬£¬£¬£¬£¬Êǹú¼ÒÖصã¸ßÐÂÊÖÒÕÆóÒµ¡¢¹ú¼ÒÊÖÒÕÁ¢ÒìÊ÷Ä£ÆóÒµ¡£¡£¡£¡£¡£¡£¡£¹«Ë¾ÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£¡£¡£¡£¡£¡£¡£¸ü¶àÐÅÏ¢Çë»á¼û£º/¡£¡£¡£¡£¡£¡£¡£

²Î¿¼×ÊÁÏ£º

1. Zhang P, Jiang Y, Xu C et al. Pegmolesatide for the treatment of anemia in patients undergoing dialysis: a randomized clinical trial. EClinicalMedicine. 2023 Oct 28:65:102273. doi: 10.1016/j.eclinm.2023.102273. 

2.Xie,Jianteng et al. Randomized Trial of Pegmolesatide for the Treatment of Anaemia in Patients with Non-Dialysis Chronic Kidney Disease. Kidney International Reports.2024.https://doi.org/10.1016/j.ekir.2024.12.002. In Press.


ÉùÃ÷£º
1¡¢º²É­ÖÆÒ©²»ÍƼöÈκÎδ»ñÅúҩƷʹÓûòδ»ñÅú˳Ӧ֢ÓÃÒ©¡£¡£¡£¡£¡£¡£¡£

2¡¢±¾ÐÂΟåÖеÄÒ½ÁÆÐÅÏ¢½ö¹©ÐÅÏ¢ºÍÐÂÎű¨µÀʹÓà £¬£¬£¬£¬£¬£¬²»±ØÓÚ¹ã¸æÄ¿µÄ £¬£¬£¬£¬£¬£¬²»Òª½«ÆäÓÃÓÚÒ½ÁƱ£½¡»òÕï¶Ï½¨Òé¡£¡£¡£¡£¡£¡£¡£



Ç°Õ°ÐÔ˵Ã÷



±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚº²É­ÖÆÒ©¼¯ÍÅÓÐÏÞ¹«Ë¾¼°ÆäÁ¥Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾ £¬£¬£¬£¬£¬£¬Í³³ÆΪ¡°º²É­ÖÆÒ©¡±£©µÄÐÅÏ¢¡£¡£¡£¡£¡£¡£¡£Ëü²»×é³É¶Ôº²É­ÖÆÒ©»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£¡£¡£¡£¡£¡£¡£

±¾ÐÂΟå°üÀ¨µÄÐÅÏ¢¿ÉÄÜ°üÀ¨Ó뺲ɭÖÆÒ©ÓªÒµºÍ²úÆ·Ô¶¾°¡¢ÍýÏë¡¢ÐÅÐÄ¡¢Ô¤ÆÚºÍÕ½ÂÔÏà¹ØµÄÇ°Õ°ÐÔÉùÃ÷¡£¡£¡£¡£¡£¡£¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍƲâÐÔ¼ÙÉèµÄÕ¹Íû £¬£¬£¬£¬£¬£¬²¢²»°ü¹ÜδÀ´µÄÌåÏÖ¡£¡£¡£¡£¡£¡£¡£ËüÃÇÊܵ½ÖîÈç¿Æѧ¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾­¼Ã¡¢²ÆÎñ¡¢Ö´·¨ÒòËØÒÔ¼°¾ºÕùÇéÐκÍÉç»áÌõ¼þµÈΣº¦ºÍ²»È·¶¨ÐÔµÄÓ°Ïì £¬£¬£¬£¬£¬£¬ÕâЩÒòËØÐí¶à¶¼ÊǺ²É­ÖÆÒ©ÎÞ·¨¿ØÖÆÇÒÄÑÒÔÕ¹ÍûµÄ £¬£¬£¬£¬£¬£¬Òò´ËÏÖʵЧ¹û¿ÉÄÜÓë´ËµØ·½ÊöÓÐÏÔÖø²î±ð £¬£¬£¬£¬£¬£¬ÇÒÒÑÍùµÄ֤ȯ¼ÛÇ®Ç÷ÊƲ»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£¡£¡£¡£¡£¡£¡£Òò´Ë £¬£¬£¬£¬£¬£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢¾ÙÐÐͶ×ʾöÒéʱӦÉóÉ÷ÐÐÊ¡£¡£¡£¡£¡£¡£¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÐÅÍС±¡°Õ¹Íû¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°ÍýÏ롱¡°¼ÌÐø¡±¡°Ä¿µÄ¡±¡°Ë¼Á¿¡±¡°Ô¤¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´ÍýÏë¡¢Ðж¯»òÊÂÎñµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓï £¬£¬£¬£¬£¬£¬¾ùÌåÏÖÇ°Õ°ÐÔÉùÃ÷¡£¡£¡£¡£¡£¡£¡£

º²É­ÖÆÒ©²»ÔÊÐí»ò°ü¹ÜÇ°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢ÊµÊ±ÐÔ»òÍêÕûÐÔ £¬£¬£¬£¬£¬£¬²¢ÇÒ²»¼ç¸º¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£¡£¡£¡£¡£¡£¡£ÎÞÂÛÊǺ²É­ÖÆÒ©ÕÕ¾ÉÆäÈκζ­Ê¡¢Ô±¹¤»òÊðÀíÈË £¬£¬£¬£¬£¬£¬¾ù²î³ØÈκÎ֤ʵ½û¾øÈ·»òÎÞ·¨ÊµÏÖµÄÇ°Õ°ÐÔÉùÃ÷ÈÏÕæ £¬£¬£¬£¬£¬£¬Ò²²î³ØÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø±¬·¢µÄÈκÎËðʧ»òËðº¦ÈÏÕæ £¬£¬£¬£¬£¬£¬°üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢ÎÞÒâ¡¢¼ä½Ó»ò´¦·ÖÐÔµÄË𺦡£¡£¡£¡£¡£¡£¡£

±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢¾ùΪÐû²¼Ö®ÈÕµÄ×îÐÂÐÅÏ¢¡£¡£¡£¡£¡£¡£¡£º²É­ÖÆÒ©²»¼ç¸ºÒòÐÂÉú³¤¡¢Î´À´ÊÂÎñ»òÆäËûÇéÐζø¸üлòÐÞ¶©ÕâЩÐÅÏ¢µÄÔðÈÎ £¬£¬£¬£¬£¬£¬³ý·ÇÖ´·¨ÒªÇ󡣡£¡£¡£¡£¡£¡£±ðµÄ £¬£¬£¬£¬£¬£¬º²É­ÖÆÒ©±£±£´æÈκÎʱ¼äδ¾­Í¨Öª¶Ô±¾ÐÂΟåµÄËùÓлò²¿·ÖÄÚÈݾÙÐиü¸Ä¡¢¸üÕý»òÖÐÖ¹µÄȨÁ¦¡£¡£¡£¡£¡£¡£¡£¹ØÓÚÌØÊâÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢ £¬£¬£¬£¬£¬£¬¹«Ë¾ÃãÀøͶ×ÊÕ߲ο¼º²É­ÖÆÒ©£¨03692.HK£©µÄͨ¸æºÍ²ÆÎñ±¨¸æ¡£¡£¡£¡£¡£¡£¡£


END

ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾
¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿